Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants
- DOI
- 10.1038/s41591-026-04439-x
- Published
- 2026-06
- Container
- Nature Medicine
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-026-04439-x,
title = {Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants},
author = {Nicholas A. Marston and Shinwan Kany and Giorgio E. M. Melloni and Sean J. Jurgens and Frederick K. Kamanu and Yi-Pin Lai and Joel T. Rämö and Itamar Raz and Stephen D. Wiviott and Patrick T. Ellinor and Marc S. Sabatine and Christian T. Ruff},
year = {2026},
journal = {Nature Medicine},
doi = {10.1038/s41591-026-04439-x},
url = {https://doi.org/10.1038/s41591-026-04439-x}
}RIS
TY - JOUR TI - Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants AU - Nicholas A. Marston AU - Shinwan Kany AU - Giorgio E. M. Melloni AU - Sean J. Jurgens AU - Frederick K. Kamanu AU - Yi-Pin Lai AU - Joel T. Rämö AU - Itamar Raz AU - Stephen D. Wiviott AU - Patrick T. Ellinor AU - Marc S. Sabatine AU - Christian T. Ruff PY - 2026 JO - Nature Medicine DO - 10.1038/s41591-026-04439-x UR - https://doi.org/10.1038/s41591-026-04439-x ER -
APA
Marston, N. A., Kany, S., Melloni, G. E. M., Jurgens, S. J., Kamanu, F. K., Lai, Y., Rämö, J. T., Raz, I., Wiviott, S. D., Ellinor, P. T., Sabatine, M. S., & Ruff, C. T. (2026). Effects of SGLT2 inhibition on incident heart failure in carriers of cardiomyopathy-associated genetic variants. Nature Medicine. https://doi.org/10.1038/s41591-026-04439-x
Source records
- crossref · retrieved 2026-09-26T21:49:44.214Z